Evidence map›Paper›PMID 35442982›Full record

ArticlePloS one2022

Antimicrobial prophylaxis does not improve post-surgical outcomes in SIV/SHIV-uninfected or SIV/SHIV-infected macaques (Macaca mulatta and Macaca fascicularis) based on a retrospective analysis.

Cassandra Moats, Kimberly Cook, Kimberly Armantrout, Hugh Crank, Samantha Uttke, Kelly Maher, Rachele M Bochart, George Lawrence, Michael K Axthelm, Jeremy V Smedley

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Liver-specific transgenic expression of human NTCP in rhesus macaques confers HBV susceptibility on primary hepatocytes.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Mayaro virus pathogenesis and immunity in rhesus macaques.PLoS neglected tropical diseases · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Cassandra MoatsInfectious Disease Resource, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.ORCID 0000-0002-3978-7408
Kimberly CookInfectious Disease Resource, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Kimberly ArmantroutInfectious Disease Resource, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Hugh CrankInfectious Disease Resource, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.ORCID 0000-0003-0064-9574
Samantha UttkeInfectious Disease Resource, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Kelly MaherInfectious Disease Resource, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Rachele M BochartInfectious Disease Resource, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
George LawrenceDirector's Office, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Michael K AxthelmInfectious Disease Resource, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Jeremy V SmedleyInfectious Disease Resource, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.
Oregon National Primate Research Center · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
Phase 2 Enhancement of Outdoor Group Housing for U42 SPF 9 Rhesus MacaquesU42OD023038 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI RUDOLF Paul BOHM, Lauren Drew Martin · 2016 to 2026
$21.9M
NIH HHS P51 OD011092NIH HHS U42 OD023038
6 · The paper itself

Abstract

Surgical antimicrobial prophylaxis is indicated when performing contaminated surgeries, when specific surgical implants are placed, and for prolonged surgical procedures. Unnecessary prophylactic antibiotics are often utilized for macaque surgeries, despite medical and veterinary guidelines. In this study we compared complication rates in macaques receiving peripheral lymph node (PLN) and laparoscopic biopsies, with and without antimicrobial prophylaxis. A majority of animals were SIV or SHIV infected at the time of surgery, so we also compared post-operative complication rates based on infection status. We found no significant difference in PLN biopsy complication rates for animals that received antimicrobial prophylaxis versus those that did not. Animals who underwent laparoscopic procedures and received prophylactic antibiotics had a higher complication rate than those who did not receive them. Complication rates did not differ significantly for SIV/SHIV infected versus uninfected animals for both laparoscopic biopsy procedures and PLN biopsy procedures. SIV/SHIV infected animals that underwent PLN biopsies had no significant difference in complication rates with and without antimicrobial prophylaxis, and SIV/SHIV infected animals receiving prophylactic antibiotics for laparoscopic biopsies had a higher complication rate than those that did not. This study suggests that perioperative prophylactic antibiotics have no role in the management of SIV/SHIV-infected and uninfected macaques undergoing clean, minimally invasive surgeries. Additionally, we recommend eliminating unnecessary antibiotic use in study animals due to their potential confounding impacts on research models and their potential to promote antimicrobial resistance.

Indexed as

Anti-Infective AgentsHIV-1Simian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusAnimalsAnti-Bacterial AgentsMacaca fascicularisMacaca mulattaRetrospective StudiesTreatment OutcomeAnti-Bacterial AgentsAnti-Infective Agents

Identifiers

PMID35442982
PMCPMC9020680
OpenAlexW4224224299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.